REQUEST A DEMO
Total
USD $0.00
Search more companies

Genetic S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Genetic S.A.S. Profile Updated: May 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Genetic S.A.S. is a company in Colombia, with a head office in Cali. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on February 23, 2023. It currently has a total number of 30 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 126.87% in 2024. Over the same period, its total assets grew by 123.07%. The net profit margin of Genetic S.A.S. decreased by 1.91% in 2024.

Headquarters
Kr 11 B # 37 - 09
Cali; Valle del Cauca;

Contact Details: Purchase the Genetic S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Genetic S.A.S. report to view the information.
Financial Auditors:
Purchase the Genetic S.A.S. report to view the information.
Incorporation Date:
February 23, 2023
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Genetic S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
126.87%
Total operating revenue
126.87%
Operating profit (EBIT)
47.77%
Net Profit (Loss) for the Period
19.75%
Total Assets
123.07%
Total Equity
30.14%
Operating Profit Margin (ROS)
-1.37%
Net Profit Margin
-1.91%
Return on Equity (ROE)
-1.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?